Limitations of glycosylated haemoglobin as an index of glucose intolerance

Citation
C. Snehalatha et al., Limitations of glycosylated haemoglobin as an index of glucose intolerance, DIABET RE C, 47(2), 2000, pp. 129-133
Citations number
16
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
DIABETES RESEARCH AND CLINICAL PRACTICE
ISSN journal
01688227 → ACNP
Volume
47
Issue
2
Year of publication
2000
Pages
129 - 133
Database
ISI
SICI code
0168-8227(200002)47:2<129:LOGHAA>2.0.ZU;2-7
Abstract
This study was conducted (a) to establish a normal cut-off value for glycos ylated haemoglobin measured as HbA(1a) in South Indian subjects, and (b) to evaluate its usefulness in demarcating different categories of glucose int olerance. HbA(1c) measurement was carried out in 1261 cases with no known h istory of diabetes, while being tested by oral glucose tolerance test (M:F 850:411, mean age 40 +/- 12 years). An immunoturbidimetric procedure for Hb A(1c) assay (Tina-Quant, Boehringer Mannheim, Germany) was used. The specif icity and sensitivity of HbA(1c) in demarcating normal glucose tolerance (N GT) from abnormal tolerance were calculated using the ROC procedure. By the ROC analysis, a cut-off Value of HbA(1c) greater than or equal to 6.0% gav e a sensitivity of 88.5% and specificity of 62.8% using the WHO criteria (2 -h plasma glucose greater than or equal to 200 mg/dl). Using the ADA criter ion (fasting plasma glucose > 125 mg/dl) the sensitivity and specificity fo r the same cut-off value were 85.2 and 61.2%. In NGT, only a small percenta ge of the variance in HbA(1c) was explained by the fasting plasma glucose ( FPG) values. The overall correlation coefficient between the fasting plasma glucose and HbA(1c) was r = 0.8, r(2) = 0.64 and, in the case of 2-h post glucose, r = 0.82, r(2) = 0.67. This showed that more than 35% of the varia tions in HbA,, were not explained by the plasma glucose values. The study s howed that HbA(1c) values of 2 6.0% gave a reasonably high sensitivity and specificity for diagnosis using the WHO or ADA criteria. However, nearly 35 % of the variations in HbA(1c) were not explained by the variations in plas ma glucose. Wide inter-individual variations even in the normoglycaemic ran ge make the test unsuitable for diagnostic purpose. (C) 2000 Elsevier Scien ce Ireland Ltd. All rights reserved.